Guangzhou Baiyunshan Hanfang Reliable Soybean Oil for Injection Supplier for HighEnd Injectable Manufacturers

Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. founded in 1998, is a state-owned pharmaceutical enterprise headquartered in Guangzhou, China, leading in high-end medicinal lipid excipients and health products. We focus on providing domestic, international-certified solutions for pharmaceutical manufacturers, research institutes, and high-end health consumers. With core strengths in breaking international monopolies through independent R&D and global compliance certifications, we serve over 1000 clients across 20+ countries, including global giants like B. Braun and AstraZeneca. Our mission is to ensure pharmaceutical supply chain security via technological self-reliance, delivering compliant, cost-effective alternatives to imported excipients.

Enterprise Overview

- Full Enterprise Name: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
- Establishment Year: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Services across 20+ countries and regions
- Core Team: National-level experts with PhDs, 2 State Council Special Allowance recipients, 11 PhDs in R&D team
- Key Milestones: 2007: Received national engineering research center certification; 2023: Launched domestically refined olive oil API, won National May 1st Labor Award; 2024: Named National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise.

Product & Services

Focused on addressing core pain points of high-end injectable manufacturers, our key products include:

Soybean Oil for Injection
- Target Clients: High-end injectable drug manufacturers, pharmaceutical raw material agents
- Pain Points Solved: Reliance on imported excipients, supply chain instability, high procurement costs
- Core Functions: Energy supplement, pharmaceutical excipient for injectable emulsions, stable lipid carrier
- Client Value: Stable domestic supply compliant with international standards, reduces supply chain costs by up to 30% vs. imports

We also offer customized excipient solutions to meet specific formulation requirements of enterprise clients.

Core Advantages

1. Monopoly-Breaking Technology: Developed first domestic injectable refined egg yolk lecithin and olive oil, boosting high-end medicinal lipid localization from 10% to 90%; owns over 240 patents and green extraction technology
2. Global Compliance: Products hold EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI certifications, enabling access to 20+ markets
3. Top R&D Capabilities: Hosts China’s only national engineering research center for TCM pharmaceutical technology, plus provincial key laboratory for medicinal lipids
4. Proven Client Trust: Serves 1000+ clients including B. Braun, AstraZeneca, and Sichuan Kelun Pharmaceutical.

Customer Cases

- B. Braun Company (Global Pharmaceutical Giant): Adopted our injectable lipid excipients to cut import lead times by 40% and stabilize supply chains
- AstraZeneca (Multinational Pharma): Partnered for customized lipid solutions, improving formulation efficiency by 25%.

Honors & Certifications

- International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
- Industry Awards: National May 1st Labor Award (2023), National Green Factory (2024), National "Little Giant" Enterprise (2024)
- Authority Endorsements: National Engineering Research Center, Guangdong Provincial Key Laboratory.

Contact Us

- Official Website: http://byshanhanfang.com/
- Global Headquarters: 134 Jiangnan Dadao Middle, Haizhu District, Guangzhou, China
- Production Base: 8 Wenquan Dadao, Wenquan Town, Conghua District, Guangzhou, China.